Actually that report is inaccurate on one critical point; that Lynas 'cannot capture premium pricing' due to the Sojitz supply agreement 'at prevailing market prices'. That's a misunderstanding of the Sept 2022 update of the supply agreement.
https://wcsecure.weblink.com.au/pdf/LYC/02564226.pdf
Here's the key quote:
Lynas shall ensure that in the event of competing demands from the Japanese market and a non-Japanese market for the supply by the Borrower or Lynas Malaysia for NdPr produced from the LAMP, the Japanese market shall have priority of supply up to 7,200tonnes per year subject to the terms of the Availability Agreement and to the extent that Lynas will not have any opportunity loss.
So the agreement makes no reference to 'prevailing market prices' and only guarantees to give the Japanese priority supply so long a they are willing to match other potential customers. There are similar but weaker clauses covering potential outputs from Texas and NdPr production over 7.2kt.
- Forums
- ASX - By Stock
- LYC
- Interesting article
LYC
lynas rare earths limited
Add to My Watchlist
1.20%
!
$9.07

Interesting article, page-385
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$9.07 |
Change
-0.110(1.20%) |
Mkt cap ! $8.484B |
Open | High | Low | Value | Volume |
$9.21 | $9.30 | $9.03 | $23.21M | 2.549M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5182 | $9.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.09 | 12000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5182 | 9.060 |
2 | 1600 | 9.040 |
4 | 13255 | 9.030 |
3 | 3547 | 9.020 |
5 | 23138 | 9.010 |
Price($) | Vol. | No. |
---|---|---|
9.090 | 12000 | 2 |
9.110 | 3527 | 3 |
9.120 | 8899 | 2 |
9.130 | 11630 | 1 |
9.140 | 11630 | 1 |
Last trade - 16.11pm 25/06/2025 (20 minute delay) ? |
Featured News
LYC (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online